First Line Hepato Cellular Carcinoma (HCC)

Clinical trial NCT00858871 · COMPLETED

Trial details

NCT number: NCT00858871
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepato Cellular Carcinoma (HCC)

Start date: 2009-05-01
Primary completion: 2012-06-01
Enrollment: 1714

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.